-
My Account
In App
My Account
BSE Live
Oct 28, 16:01Prev. Close
2414.90
Open Price
2414.90
Bid Price (Qty.)
2406.50 (50)
Offer Price (Qty.)
2414.20 (50)
NSE Live
Oct 28, 15:41Prev. Close
2416.70
Open Price
2416.70
Bid Price (Qty.)
2406.50 (34)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Mankind Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 41.26 | 40.06 | 40.06 | 40.06 | 40.06 | |
| Total Share Capital | 41.26 | 40.06 | 40.06 | 40.06 | 40.06 | |
| Reserves and Surplus | 14,599.01 | 9,560.50 | 7,743.85 | 6,028.72 | 4,694.21 | |
| Total Reserves and Surplus | 14,599.01 | 9,560.50 | 7,743.85 | 6,028.72 | 4,694.21 | |
| Total Shareholders Funds | 14,640.27 | 9,623.81 | 7,783.91 | 6,068.77 | 4,734.27 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 4,942.69 | 0.00 | 0.00 | 2.44 | 0.00 | |
| Deferred Tax Liabilities [Net] | 17.32 | 71.59 | 55.85 | 35.71 | 0.00 | |
| Other Long Term Liabilities | 10.42 | 17.16 | 23.40 | 15.23 | 10.77 | |
| Long Term Provisions | 126.10 | 111.79 | 88.87 | 62.69 | 56.39 | |
| Total Non-Current Liabilities | 5,096.53 | 200.54 | 168.12 | 116.06 | 67.15 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 2,305.56 | 0.00 | 0.00 | 685.45 | 95.00 | |
| Trade Payables | 563.62 | 849.52 | 801.96 | 924.88 | 594.08 | |
| Other Current Liabilities | 670.09 | 370.73 | 322.53 | 383.04 | 203.04 | |
| Short Term Provisions | 552.25 | 373.11 | 294.59 | 234.63 | 186.79 | |
| Total Current Liabilities | 4,091.52 | 1,593.36 | 1,419.09 | 2,228.01 | 1,078.91 | |
| Total Capital And Liabilities | 23,828.32 | 11,417.71 | 9,371.12 | 8,412.85 | 5,880.33 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 1,941.45 | 1,811.33 | 1,435.81 | 1,039.87 | 965.38 | |
| Intangible Assets | 1,529.30 | 1,587.75 | 1,701.08 | 1,841.27 | 16.58 | |
| Capital Work-In-Progress | 191.36 | 112.88 | 437.83 | 355.28 | 165.51 | |
| Other Assets | 0.00 | 5.27 | 5.32 | 5.38 | 5.46 | |
| Fixed Assets | 3,678.18 | 3,591.92 | 3,637.00 | 3,273.08 | 1,152.98 | |
| Non-Current Investments | 15,124.52 | 2,190.62 | 2,040.76 | 1,760.67 | 1,500.86 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 13.04 | |
| Long Term Loans And Advances | 9.46 | 8.74 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 320.15 | 136.01 | 176.45 | 122.32 | 123.47 | |
| Total Non-Current Assets | 19,132.31 | 5,927.30 | 5,854.21 | 5,156.07 | 2,790.35 | |
| CURRENT ASSETS | ||||||
| Current Investments | 1,558.86 | 2,239.51 | 1,061.47 | 387.77 | 896.03 | |
| Inventories | 1,090.98 | 1,075.59 | 1,032.22 | 1,225.79 | 826.91 | |
| Trade Receivables | 894.67 | 749.47 | 492.64 | 517.29 | 369.17 | |
| Cash And Cash Equivalents | 305.87 | 761.01 | 155.15 | 73.19 | 476.95 | |
| Short Term Loans And Advances | 10.62 | 39.92 | 98.34 | 145.75 | 227.17 | |
| OtherCurrentAssets | 835.01 | 624.91 | 677.09 | 906.98 | 293.75 | |
| Total Current Assets | 4,696.01 | 5,490.41 | 3,516.91 | 3,256.78 | 3,089.98 | |
| Total Assets | 23,828.32 | 11,417.71 | 9,371.12 | 8,412.85 | 5,880.33 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 4,261.71 | 449.91 | 168.37 | 275.47 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 257.59 | 164.91 | 87.07 | 102.84 | 65.28 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 922.93 | 649.50 | 179.52 | 195.02 | 192.42 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.19 | 5.19 | 5.19 | 5.19 | 5.19 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 15,124.52 | 2,190.62 | 2,040.76 | 1,760.67 | 1,500.86 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 1,558.86 | 2,239.51 | 1,061.47 | 387.77 | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | 896.03 |
13.10.2025
19.09.2025
11.09.2025
05.08.2025
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y
24.06.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y
22.05.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y
